(US) BGC Partners, Inc. engages in the provision of brokerage services to the financial markets. The firm offers integrated voice, hybrid, and fully electronic brokerage in a broad range of products, including fixed income, foreign exchange, equities, insurance, energy and commodities, and futures. It also provides trade execution, brokerage, clearing, trade compression, post-trade, information, and other back-office services. The company was founded in 1945 and is headquartered in New York, NY.
BlackRock Capital Investment Corp., a Traded Fund, invests in middle market companies located in the US and Canada. The fund focuses on companies with revenues ranging from $50 million to $1 billion, strong management teams, defensible market positions and positive cash flows. It targets companies operating across a broad range of sectors. It provides financing in the form of equity, mezzanine and debt investments with an investment size of $10 - $50 million.
(United States) Blucora, Inc. engages in the provision of technology-enabled, tax-smart financial solutions. It operates through the Wealth Management, and Tax Preparation segments. The Wealth Management segment consists of the operations of Avantax, which provides tax-focused wealth management solutions for financial advisors, tax preparers, certified public accounting firms, and its clients. The Tax Preparation segment focuses on digital tax preparation solutions for consumers, small business owners, and tax professionals. The company was founded by Naveen Mahendra Kumar Jain in March 1996 and is headquartered in Irving, TX.
(BE) Celyad Oncology SA engages in the development of cell-based therapies for the treatment of cancer. It operates through the following segments: Cardiology, Immuno-oncology, and Corporate. The Cardiology segment includes the company's Cardiopoiesis, Corquest, and C-Cathez platforms. The Immuno-oncology segment consists of all assets developed based on the CAR-T cell platform. The company was founded by Michel Lussier, William Wijns, and Christian Homsy on July 24, 2007 and is headquartered in Mont-Saint-Guibert, Belgium.
Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY.
Citrix Systems, Inc. engages in the design, development, and marketing of information technology solutions. It provides digital workspace that unifies apps, data, and services. It markets and licenses its products directly to customers through web, systems integrators, value-added resellers, and service providers. The company was founded by Edward E. Iacobucci on April 17, 1989 and is headquartered in Fort Lauderdale, FL.
Chase Corp. operates as a chemical company, which manufactures materials for high-reliability applications. It operates through the following segments: Adhesives, Sealants and Additives, Industrial Tapes, and Corrosion Protection and Waterproofing. The Adhesives, Sealants, and Additives segment offers innovative and specialized product offerings consisting of both end-use products and intermediates that are used in or integrated into another company’s products. The Industrial Tapes segment features legacy wire and cable materials, specialty tapes, and other laminated and coated products. The Corrosion Protection and Waterproofing segment composes of project-oriented product offerings that are primarily sold and used as Chase branded products. The company was founded by Francis M. Chase and Edward L. Chase in 1946 and is headquartered in Westwood, MA.
(CA) Gold Standard Ventures Corp. operates as a mineral exploration company. The firm engages in the business of acquisition and exploration. It focuses the following projects: Carlin Trend, Railroad-Pinion, and Lewis. The company was founded by Luke A. Norman and Jonathan Charles Timothy Awde on February 6, 2004 and is headquartered in Vancouver, Canada.
Maverix Metals, Inc. engages in the evaluation and acquisition of mining royalties and precious metals streams. Its assets include La Colorada, San Jose, Mt. Carlton, Vivien, Beta Hunt, Silvertrip, Florida Canyon, Moose River, Shalipayco, and Romero. The company was founded by Geoffrey A. Burns and Daniel O'Flaherty on January 9, 2016 and is headquartered in Vancouver, Canada.
(US) Sanchez Midstream Partners LP engages in the acquisition, development, and production of oil and natural gas properties and related assets. The company operates through the following segments: Midstream and Production. The Midstream segment operates the gathering, processing, and transportation of natural gas. The Production segment consists of oil and natural gas properties in Texas and Louisiana. The company was founded on February 7, 2005 and is headquartered in Houston, TX.
(DE) Spark Networks SE operates as a holding company. The firm engages in the operation of online dating sites and applications. It operates through the following segments: North America and International. The North America segment consists of the firm's operations in the United States and Canada. The International segment includes all other operations except for the United States and Canada. The company was founded on April 5, 2017 and is headquartered in Berlin, Germany.
(United States) Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.
Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline is OCALIVA which is used for the treatment of primary biliary cholangitis, nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.
(US) Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company was founded by Joseph P. Vacanti, Frank M. Reynolds, and Robert Langer in January 2005 and is headquartered in Cambridge, MA.
IVERIC bio, Inc. is a biopharmaceutical company which engages in discovering, developing, and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in New York, NY.
Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders.The company was founded in July 2009 by Andrew Miller, Eric Elenko and Peter Jeffrey Conn and is headquartered in Boston, MA.
(US) La Jolla Pharmaceutical Co. operates as a biopharmaceutical company, which engages in the discovery, development and commercialization of therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. Its products includes LJPC-501, LJPC-401 and LJPC-0118. LJPC-501 is the proprietary formulation for angiotensin II. The LJPC-401 is the formulation of hepcidin, which is an endogenous peptide hormone and LJPC-0118 is La Jolla’s investigational product for the treatment of severe malaria. The company was founded in 1989 and is headquartered in San Diego, CA.
Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of hematologic diseases and cancers. Its product pipeline consists of FT-4202 for the treatment of sickle cell disease and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company was founded by Michael A. Foley in December 2011 and is headquartered in Watertown, MA.
(US) Genius Brands International, Inc. is a content and brand management company, which engages in developing, producing, marketing, and licensing branded children’s entertainment properties and consumer products for media distribution and retail channels. The firm acts as a licensing agent for certain brands, such as Llama Llama, Psycho Bunny, From Frank, and Celessence Technologies. The company was founded by Balaban Howard Alan on January 2, 2006 and is headquartered in Beverly Hills, CA.
Hailiang Education Group, Inc. engages in the provision of private K-12 educational services. It offers basic educational and international programs for kindergarten, primary, middle, and high school levels. The company was founded in 1995 and is headquartered in Hangzhou, China.